文献速递心力衰竭与心肌病血脂与心血管预防

新冠康复学生运动员心肌炎的心脏磁共振评估

Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging.
PubMed 文献 · JAMA Cardiol · 2021-01-01

该病例系列在威斯康星大学连续纳入145名新冠康复的竞技学生运动员,于新冠阳性后中位15天行钆增强心脏磁共振,按更新版Lake Louise标准判读。仅2例(1.4%,95%CI 0.4%-4.9%)符合心肌炎表现,提示在该无症状或轻中度症状人群中筛查心肌炎的效用存疑。

要点

  • 新冠康复学生运动员中心肌炎MRI检出率低,为1.4%。
  • 多数患者急性期症状轻微、中度或无症状,无人住院。
  • 心脏磁共振作为该人群心肌炎筛查工具的效用存疑。

核心结论

  • 在新冠康复且无或仅有轻中度症状的学生运动员中,基于MRI的心肌炎患病率低(1.4%),心脏磁共振作为筛查工具的效用存疑。

研究设计与样本

  • 本研究为病例系列,在威斯康星大学通过电子健康记录检索连续纳入2020年1月1日至2020年11月29日期间新冠康复并接受钆增强心脏磁共振的竞技学生运动员。
  • 共纳入145名竞技学生运动员(108名男性,37名女性;平均年龄20岁,范围17-23岁),新冠感染经逆转录聚合酶链反应检测确认。
  • MRI结果由2名心脏影像经验丰富的放射科医生依据更新版Lake Louise标准审阅,同时获取心肌损伤与炎症血清标志物、心电图、经胸超声心动图及相关临床数据。

主要发现

  • 急性感染期间多数患者症状轻微(71例,49.0%)、中度(40例,27.6%)或无症状(24例,16.6%),10例(6.9%)症状未明确或未记录,无人需要住院。
  • 心脏磁共振在新冠检测阳性后中位15天(范围11-194天)进行。
  • 2例患者MRI表现符合心肌炎(1.4% [95%CI,0.4%-4.9%])。
  • 其中1例在多节段出现显著非缺血性晚期钆增强和T2加权信号异常,伴血清肌钙蛋白-I水平异常;另1例有1厘米非缺血性轻度晚期钆增强和轻度T2加权信号异常,实验室检查正常。

临床怎么用

  • 对于新冠康复后无或仅有轻中度症状的竞技学生运动员,不应常规以心脏磁共振作为心肌炎筛查工具。

局限性

  • 本研究为单中心病例系列,样本为连续接受心脏磁共振的竞技学生运动员,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The utility of cardiac magnetic resonance imaging (MRI) as a screening tool for myocarditis in competitive student athletes returning to training after recovering from coronavirus disease 2019 (COVID-19) infection is unknown. OBJECTIVE: To describe the prevalence and severity of cardiac MRI findings of myocarditis in a population of competitive student athletes recovering from COVID-19. DESIGN, SETTING, AND PARTICIPANTS: In this case series, an electronic health record search was performed at our institution (University of Wisconsin) to identify all competitive athletes (a consecutive sample) recovering from COVID-19, who underwent gadolinium-enhanced cardiac MRI between January 1, 2020, and November 29, 2020. The MRI findings were reviewed by 2 radiologists experienced in cardiac imaging, using the updated Lake Louise criteria. Serum markers of myocardial injury and inflammation (troponin-I, B-type natriuretic peptide, C-reactive protein, and erythrocyte sedimentation rate), an electrocardiogram, transthoracic echocardiography, and relevant clinical data were obtained. EXPOSURES: COVID-19 infection, confirmed using reverse transcription-polymerase chain reaction testing. MAIN OUTCOMES AND MEASURES: Prevalence and severity of MRI findings consistent with myocarditis among young competitive athletes recovering from COVID-19. RESULTS: A total of 145 competitive student athletes (108 male and 37 female individuals; mean age, 20 years; range, 17-23 years) recovering from COVID-19 were included. Most patients had mild (71 [49.0%]) or moderate (40 [27.6%]) symptoms during the acute infection or were asymptomatic (24 [16.6%]). Symptoms were not specified or documented in 10 patients (6.9%). No patients required hospitalization. Cardiac MRIs were performed a median of 15 days (range, 11-194 days) after patients tested positive for COVID-19. Two patients had MRI findings consistent with myocarditis (1.4% [95% CI, 0.4%-4.9%]). Of these, 1 patient had marked nonischemic late gadolinium enhancement and T2-weighted signal abnormalities over multiple segments, along with an abnormal serum troponin-I level; the second patient had 1-cm nonischemic mild late gadolinium enhancement and mild T2-weighted signal abnormalities, with normal laboratory values. CONCLUSIONS AND RELEVANCE: In this case series study, based on MRI findings, there was a low prevalence of myocarditis (1.4%) among student athletes recovering from COVID-19 with no or mild to moderate symptoms. Thus, the utility of cardiac MRI as a screening tool for myocarditis in this patient population is questionable.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021. PMID: 33443537. doi:10.1001/jamacardio.2020.7444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。